Search Results for "lovastatin"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for lovastatin. Results 1 to 6 of 6 total matches.
Comparison Chart: Statins (online only)
The Medical Letter on Drugs and Therapeutics • Jun 08, 2026 (Issue 1756)
with other drugs
▪ Simvastatin and lovastatin are metabolized by CYP3A4; concurrent use of strong CYP3A4 ...
View the Comparison Chart: Statins
Med Lett Drugs Ther. 2026 Jun 8;68(1756):e94-5 doi:10.58347/tml.2026.1756b | Show Introduction Hide Introduction
Table 3: Some Drug Interactions with DAAs for HCV Infection (online only)
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024 (Issue 1714)
Not recommended
Efavirenz Decreased DAA serum concentrations Not recommended
Atorvastatin, lovastatin ...
View Table 3: Some Drug Interactions with DAAs for HCV Infection
Med Lett Drugs Ther. 2024 Oct 28;66(1714):e175 doi:10.58347/tml.2024.1714f | Show Introduction Hide Introduction
Comparison Table: Some Lipid-Lowering Drugs (online only)
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
and lovastatin are metabolized by CYP3A4; concurrent
use of strong CYP3A4 inhibitors7 can increase their serum ...
View the Comparison Table: Some Lipid-Lowering Drugs
Drugs for Hypercholesterolemia
The Medical Letter on Drugs and Therapeutics • Jun 08, 2026 (Issue 1756)
interactions. Simvastatin and lovastatin undergo
extensive first-pass metabolism by CYP3A4; concurrent use ...
Recently published multisociety guidelines for the
management of dyslipidemia emphasize early identification
and treatment of dyslipidemia to reduce the lifetime risk of
atherosclerotic cardiovascular disease (ASCVD) and death.
Med Lett Drugs Ther. 2026 Jun 8;68(1756):89-95 doi:10.58347/tml.2026.1756a | Show Introduction Hide Introduction
Lipid-Lowering Drugs
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
can be
precipitated by drug interactions. Simvastatin and
lovastatin undergo extensive first-pass ...
Cholesterol management guidelines from the
American College of Cardiology/American Heart
Association Task Force were last published in 2019.
Drugs for Hepatitis C Virus Infection
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024 (Issue 1714)
, atorvastatin, lovastatin,
simvastatin, or high-dose cyclosporine (>100 mg/day)
is not recommended.10 ...
About 2.5 million persons in the US had hepatitis C
between 2017 and 2020. Guidelines from the American
Association for the Study of Liver Diseases (AASLD)
and the Infectious Diseases Society of America (IDSA)
on management of hepatitis C virus (HCV) infection
were updated in 2023.
Med Lett Drugs Ther. 2024 Oct 28;66(1714):169-74 doi:10.58347/tml.2024.1714a | Show Introduction Hide Introduction